The developmental outcomes of preimplantation mammalian embryos are regulated directly by the surrounding microenvironment, and inappropriate concentrations of amino acids, or the loss of amino acid-sensing mechanisms, can be detrimental and impact further development. A specific role for L-proline in the differentiation of embryonic stem (ES) cells, a cell population derived from the blastocyst, has been shown in culture. L-proline acts as a signalling molecule, exerting its effects through cell uptake and subsequent metabolism. Uptake in ES cells occurs predominantly through the sodium-coupled neutral amino acid transporter 2, Slc38a2 (SNAT2). Dynamic expression of amino acid transporters has been shown in the early mammalian embryo, reflecting functional roles for amino acids in embryogenesis. The expression of SNAT2 and family member Slc38a1 (SNAT1) was determined in mouse embryos from the 2-cell stage through to the early post-implantation pre-gastrulation embryo. Key changes in expression were validated in cell culture models of development. Both transporters showed temporal dynamic expression patterns and changes in intracellular localisation as differentiation progressed. Changes in transporter expression likely reflect different amino acid requirements during development. Findings include the differential expression of SNAT1 in the inner and outer cells of the compacted morula and nuclear localisation of SNAT2 in the trophectoderm and placental lineages. Furthermore, SNAT2 expression was up-regulated in the epiblast prior to primitive ectoderm formation, an expression pattern consistent with a role for the transporter in later developmental decisions within the pluripotent lineage. We propose that the differential expression of SNAT2 in the epiblast provides evidence for an L-proline-mediated mechanism contributing to the regulation of embryonic development.
Introduction
Inadequate amino acids supplementation in the culture environment of early mammalian embryos leads to poor embryonic outcomes, suggesting a requirement for these key metabolites (Gardner and Lane, 1993; Lane and Gardner, 1994; McKiernan et al., 1995) . Functionally, amino acids protect the early embryo by acting as osmolytes (Van Winkle et al., 1990c) , buffers of intracellular pH (Edwards et al., 1998) , antioxidants (Liu and Foote, 1995) and chelators (Lindenbaum, 1973) , as well as playing canonical roles as biosynthetic precursors, energy sources (Crosby et al., 1988; Rieger et al., 1992) and regulators of carbohydrate metabolism (Gardner, 1998; Lane and Gardner, 2005) . Additional roles in cell signalling and determining cell allocation and differentiation within preimplantation embryos have been demonstrated (Lane and Gardner, 1997; Martin and Sutherland, 2001; Martin et al., 2003; Wu and Morris, 1998) . Not surprisingly, therefore, developmental outcomes of cultured early mammalian embryos are sensitive to amino acid concentrations within the medium, and successful culture requires manipulation and optimisation of the medium amino acid composition (Gardner, 1998; Gardner and Lane, 2014a; Lane and Gardner, 1997) . Conversely, death occurs around the time of implantation in embryos deficient in the amino acid sensor mTOR (Gangloff et al., 2004; Murakami et al., 2004) , implying a requirement for nutrient sensing in late preimplantation development and differentiation. Despite these observations, little is known about the role of amino acid signalling in embryogenesis.
Amino acid transporters can be highly regulated during early embryonic development (Pelland et al., 2009; Van Winkle, 2001 Van Winkle et al., 1990b) . The glycine transporter Slc6a9 (GLYT1) is essential for regulating oocyte size. GLYT1 is activated as the oocyte undergoes meiotic maturation, and activity gradually decreases with development, returning to baseline levels by the 8-cell stage (Tartia et al., 2009) . Betaine uptake by the betaine/proline transporter, Slc6a20 (SIT1), can be detected in 1-and 2-cell embryos, with activity on either side of this window at baseline (Anas et al., 2007 (Anas et al., , 2008 . GLYT1 and SIT1 transport osmolyte regulators, glycine and betaine, which protect the embryo from osmotic stress during the early cleavage stages (Baltz, 2013; Lane, 2001; Van Winkle et al., 1990c) . Slc7a9 (B 0,+ ), increases in activity 30-fold between the 1-cell embryo and the preimplantation blastocyst, after which the transporter is inactive (Van Winkle et al., 1990b) . Leucine uptake through B 0,+ activates the mTOR pathway and induces the formation of motile trophoblast cells, thereby regulating the onset of embryo penetration into the uterine wall (Van Winkle et al., 2006) . These observations suggest that the expression and activity of amino acid transporters in the embryo are dynamic, and are consistent with the known roles of, and the requirement for, amino acids in mammalian embryogenesis. The sodium-coupled neutral amino acid transporter 2, Slc38a2 (SNAT2), is expressed by pluripotent cells in culture and transporter activity is required for the formation of early primitive ectoderm-like (EPL) cells from embryonic stem (ES) cells (Tan et al., 2011) . EPL cell formation is induced from primed ES cells by L-proline (Casalino et al., 2011; Rathjen et al., 1999; Tan et al., 2011; Washington et al., 2010) . The activity associated with L-proline is specific; other amino acids (bar ornithine) and analogues of proline do not exhibit bioactivity (Casalino et al., 2011; Tan et al., 2011; Washington et al., 2010) . Transport of L-proline into the cell by SNAT2 is required for L-proline activity (Tan et al., 2011) . SNAT2 is the primary transporter of L-proline in ES cells. Competitive inhibition of the transporter prevents over 60% of total L-proline transport and stops the formation of EPL cells from ES cells (Tan et al., 2011) .
Sodium-coupled neutral amino acid transporter activity has been demonstrated in the embryo with the identification of a 2-methyl(amino)isobutyric acid (MeAIB) sensitive transporter active in the inner cell mass (ICM) (Jamshidi and Kaye, 1995) . This transporter could be SNAT2, consistent with the activity of SNAT2 in pluripotent cells in culture, or the related transporter Slc38a1 (SNAT1) (Tan et al., 2011) , as both these transporters can be identified by their ability to transport MeAIB. SNAT1 transcripts have been detected in ES and EPL cells in culture (Tan et al., 2011) . Here, the expression patterns of SNAT1 and SNAT2 in the cell lineages of the early mouse embryo have been examined here. For each transporter highly dynamic expression patterns were detected, and evidence of temporal and spatial regulation in multiple lineages of the early embryo, and key expression patterns were recapitulated using cultured cell models. We speculate that the regulation of SNAT2 in the pluripotent lineage of the embryo mirrors the role of this transporter in in vitro differentiation.
Experimental procedures

Mice
Naturally mated six-week-old female Swiss mice were used for embryo generation. Embryos were termed E0.5 on midday of the day a vaginal plug was detected. Mice were killed by cervical dislocation on E1.5, E2, E2.25, E3.5, E4.5 and E5.5. Embryos between E1.5 and E2.25 were flushed from the oviduct with G-MOPS with 5 mg/ml HSA (GMOPS+) (Gardner and Lane, 2014b ) using a 10G gauge needle. Blastocysts were flushed from of the uterine horns with G-MOPS + with a 27G gauge needle. E5.5 embryos were dissected from the decidua. (Doetschman et al., 1985) , were as described previously (Rathjen and Rathjen, 2003; Tan et al., 2011) . EPL cells were formed in response to MEDII supplementation as described (Rathjen and Rathjen, 2003) . WA30 ES cells were sourced from Dr. Marnie Blewitt, Walter and Eliza Hall, Australia and maintained in 2i medium with LIF as described (Ying et al., 2008) . To form primed WA30 ES cells, cells were cultured in serum-and LIF-containing medium (Rathjen and Rathjen, 2003) . The mouse TS cell line (Tanaka et al., 1998) , BeWo choriocarcinoma cell line (ATCC CCL-98) and JAR choriocarcinoma cell line (ATCC HTB-122) were a gift from Professor Paul Robson (The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA). BeWo cells were cultured in DMEM:F12 with 10% FCS. JAR cells were cultured in RPMI with 10% FCS. TS cells were maintained as described previously (Tanaka et al., 1998) .
Cell culture
D3 ES cells
Human ES cells (MEL2 cells, Australian Stem Cell Centre) were maintained in mTeSR™1 medium (Stemcell™ Technologies) at 37°C and 5% CO 2 in air on tissue culture treated plates (BD Falcon™) coated with Matrigel (BD Biosciences #354277) according to the manufacturer's instructions.
Immunofluorescence and confocal microscopy
Cells were cultured to 80% confluency on gelatin-treated coverslips in 6-well tissue culture cluster dishes. Cells were fixed in 4% PFA/PBS for 30 min at RT. Embryos were fixed in 4% PFA/PBS for 24 h at 4°C. Cells/embryos were permeabilized with PBST (30 min/RT) before blocking in PBS with 1% serum from the animal source of the secondary antibody) (30 min/RT). Cells/embryos were incubated overnight at 4°C with the primary antibody, washed 3× with PBS and incubated in secondary antibody solution at RT for 90 min. Primary and secondary antibodies were diluted according to Table S1 . Cells/embryos were stained with 300 nM 4′,6-diamidino-2-phenylindole (DAPI) in PBS and mounted in Vectorshield mounting medium (Vectorlabs). Imaging was performed on a Zeiss LSM 510 Meta confocal microscope or an Olympus Fluoview FV10i-LIV confocal microscope system. Images were prepared using the ImageJ software package (Schneider et al., 2012) .
Real-time quantitative PCR
RNA was isolated, DNaseI treated and cDNA was synthesized as previously described (Tan et al., 2011) . The reaction mix comprised 5× HOT FIREPol® EvaGreen® mix (Solis BioDyne), 200 nM forward and reverse primers and 1 μl of cDNA. Samples were amplified using a Roche Lightcycler® 480 Instrument II (Roche) or ViiA™ 7 Real-Time PCR System (Life Technologies™). The samples were initially heated to 95°C for 15 min followed by 40 cycles at 95°C for 15 s, 60°C for 15 s and 72°C for 30 s. The cycle threshold (Ct) values for β-actin was normalized across samples and the raw Ct values were analysed using QGene software package (Simon, 2003) .
Nuclear extractions and Western blotting
Nuclear extractions were performed using a NE-PER Nuclear and Cytoplasmic Extraction Kit (Pierce Protein Biology Products; Thermo Scientific) according to manufacturer's instructions. Western blotting was performed as described previously (Tan et al., 2011) . Antibodies were diluted in TBST according to Table S1 . Detection was performed using the Immun-Star™ WesternC™ Chemiluminescence Kit (Bio-rad #170-5070) and imaged using the Bio-rad ChemiDoc™ XRS + System, with images manipulated using the Image Lab™ software (Bio-rad #170-8265).
Statistics
Statistical analysis was performed using GraphPad Prism software. Gene expression data were analysed using the Student's t-test. Differences were considered statistically significant at p = 0.05. Data are presented as mean ± SEM.
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Results
SNAT1 and SNAT2 expression in cleavage stage embryos
Immunofluorescence was used to detect Oct4 (marker of the developing pluripotent lineage), SNAT1 and SNAT2 in embryonic day (E) 1.5, 2 and 2.25 embryos (2-cell, 4-cell and morula stage embryos, respectively.) A confocal slice ( Fig. 1 ) and a confocal stack ( Fig. S1 ) are shown for each embryonic stage.
In 2-cell embryos, a low level of cytoplasmic Oct4 was detected (most clearly seen in Fig. S1A , B). Oct4 was barely detectable in the 4-cell embryo, although faint nuclear staining was observed when a confocal stack was constructed (Fig. S1A, B) . Oct4 expression in the morula was robust, and detected in all blastomeres, but nuclear accumulation was only seen in a subset of these (Fig. 1A, B) .
SNAT1 and SNAT2 were detected in the cytoplasm and nuclei of blastomeres of the 2-cell and 4-cell stage embryo (Fig. 1A, B) . Protein detected in these early stage embryos is likely transporter accumulated within the oocyte. By the morula stage, the transporters were largely excluded from the nucleus with diffuse expression throughout the cytoplasm. SNAT2 was detected equally in all blastomeres of these embryos (Fig. 1B) . In contrast, SNAT1 was differentially detected in the blastomeres of the morula, with less immunofluorescence seen in those blastomeres internalised during the 4th cleavage event (from 8 to 16 cells, as determined by number of nuclei) (Fig. 1A) .
Sodium-coupled neutral amino acid transporter expression in pluripotent cells of the blastocyst
Sodium-coupled neutral amino acid transporter activity has been detected in the ICM of E4 blastocysts (Jamshidi and Kaye, 1995) . To refine this observation, we have analysed the expression of SNAT1 and SNAT2 in E3.5 and E4.5 blastocysts ( Fig. 2A, B) . Oct4 was detected in the nuclei of all non-dividing cells in E3.5 embryos. By E4.5, Oct4 was restricted to the nuclei of cells within the ICM and down-regulated in the trophectoderm ( Fig. 2A, B ).
SNAT1 and SNAT2 were detected in the trophectoderm of all blastocysts examined. SNAT1 immunofluorescence was primarily localised to the cytoplasm/cell surface of the trophectoderm ( Fig. 2A) , whereas SNAT2 immunoreactivity was detected in the nucleus and cytoplasm (Fig. 2B) . In comparison to the trophectoderm, the ICM of E3.5 and E4.5 blastocysts was immunodull, suggesting a lower level of expression of SNAT1 in the ICM of these embryos ( Fig. 2A) . In early E3.5 blastocysts, those that had not fully expanded, (the ICM filled over half of the blastocoel cavity), little SNAT2 immunofluorescence was detected within the cells of the ICM when compared to the trophectoderm (Fig. 2B) . In contrast, SNAT2 was detected equivalently in the ICM and trophectoderm of fully expanded blastocysts, (the ICM filled less than half of the blastocoel cavity), suggesting SNAT2 was up-regulated in the ICM during blastocyst expansion. SNAT2 expression in the ICM was maintained in E4.5 embryos (Fig. 2B) .
SNAT2 in the expanded embryo appeared to be present at approximately equal levels in the ICM and trophectoderm. To investigate this, the expression of Slc38a2 was compared in ES cells and trophoblast stem (TS) cells (Fig. 2C ). TS cells have been isolated from the trophectoderm of the mouse blastocyst and exhibit properties of the trophectoderm of the early embryo (Tanaka et al., 1998) . Slc38a2 expression was not statistically different between the cell populations, and robust expression in ES cells suggested they expressed equal or greater number of transcripts (Fig. 2C) .
SNAT1 and SNAT2 expression in pluripotent cells in culture
Naïve and primed mouse ES cells are proposed to correspond to the pluripotent cells of the early and late blastocyst, respectively (Boroviak et al., 2014; Rathjen, 2014; Ying et al., 2008) . Naïve ES cells (WA30 ES cells), derived from blastocysts in 2i medium, were maintained in 2i medium or transferred to serum-and LIF-containing medium and analysed for SNAT1 and SNAT2 expression by immunofluorescence ( Fig. 2D and E) . SNAT1 was observed at a similar intensity in the cytoplasm and/or cell surface of naïve and primed ES cells (Fig. 2D) . SNAT2 was detected in naïve ES cells, but the signal was less intense than that seen in primed cells, and the protein was distributed diffusely in the cytoplasm. In primed ES cells, the SNAT2 signal was predominantly cytoplasmic with the majority of protein concentrated in the perinuclear space (Fig. 2E) . The culture of primed D3 ES cells in 2i medium for 48 h resulted in a loss of protein organisation and strong, but diffuse, staining throughout the cytoplasm (data not shown). Western blot analysis of D3 ES cells with and without 2i medium for 48 h showed the protein to be represented by a single band running at 60 kDa and present at similar levels ( Fig. 2G ; n = 4, p = 0.82). SNAT1 was also represented by a single band running just above 70 kDa and present at similar levels in primed and naïve cells ( Fig.  2G ; n = 4, p = 0.09).
The expression of the SNAT1 encoding gene, Slc38a1, was unchanged by the culture of primed ES cells in 2i medium. In contrast, the expression of the SNAT2-ecoding gene, Slc38a2, was reduced by approximately 50% (p = 0.028) in D3 ES cells cultured in 2i medium when compared to cells cultured in serum-and LIF-containing medium (Fig. 2F) .
Nuclear localisation of Slc38a2 in trophectoderm derivatives
SNAT2 protein was detected in the nuclei of embryonic trophectoderm cells (Fig. 3A) . To investigate this somewhat paradoxical observation, the expression of SNAT1 and SNAT2 was examined in TS cells and two well-characterised human placental carcinoma cell lines: BeWo (Hertz, 1959) and JAR (Pattillo et al., 1971 ) cells. SNAT1 expression and localisation differed with the cell line. In TS cells, SNAT1 was detected on the cell surface and within small distinct aggregates adjacent to, or within, the nucleus (Fig. 3B) . Nuclear localisation was confirmed by Western blot (Fig. 3B) . In BeWo cells, SNAT1 was primarily localised to large peri-nuclear aggregates, with additional localisation to the cell surface in some areas and, in a minority of the cells, diffuse Confocal microscopy images of blastocysts (E3.5 and E4.5) stained for SNAT1 or SNAT2 (red), Oct4 (green) and for DNA (DAPI (blue)), as noted. The far right image shows the merged staining patterns. C. RNA from D3 ES cells and trophectoderm stem (TS) cells was analysed for the expression of Slc38a2 with real-time qPCR. Expression was normalized to β-actin. Error bars represent sem; n = 3. D-E. Confocal microscopy images of WA30 ES cells cultured in 2i medium (2i) or serum and LIF containing medium (S + L) analysed for the expression of SNAT1 or SNAT2 (red) and Oct4 (green) by immunofluorescence. The far right image shows the merged staining patterns. Protein accumulation in the perinuclear space is indicated with arrowheads. n = 3. Scale bar = 40 μm. F. RNA from D3 ES cells cultured in serum-and LIF-containing medium (primed) or 2i medium (naive) for 2 days was analysed for the expression of Slc38a1 and Slc38a2 with real-time PCR. Expression was normalized to β-actin and expressed relative to ES cells. Error bars represent sem; n = 4 (primed) or 8 (naive; this includes cells in 2i medium with and without LIF supplementation). * p = 0.028. G. Primed D3 ES cells (P), and primed D3 ES cells cultured in 2i medium for 48 h (N) were analysed by Western blot for SNAT1 and SNAT2. β-tubulin was used as control.
staining detected in the cytoplasm (Fig. 3B) . In JAR cells, SNAT1 staining was primarily detected in the nucleus, with some peri-nuclear aggregation and a blush of colour across the cytoplasm (Fig. 3B) . SNAT2 expression, in contrast, was much more consistent, with the protein preferentially localised to the nucleus, and with no obvious peri-nuclear aggregation or localisation to the cell surface (Fig. 3B) . Nuclear localisation was observed in TS cells stained with a second antibody specific to SNAT2 (Fig. S2) and Western blot analysis of nuclear and cytoplasmic extracts from trophoblast stem cells showed SNAT2 in both fractions (Fig. 3B) . A previous analysis of SNAT2 in BeWo cells suggested that the protein was located in the perinuclear space (Jones et al., 2006b ), but our use of confocal microscopy clearly shows SNAT2 in the nucleus.
Expression of solute carrier family 38 members in post-implantation embryos
The pluripotent population of the post-implantation embryo (E5.5 -E8.25) resides in a pseudostratified epithelium of cells, the primitive ectoderm, in the distal portion of the embryo (Lake et al., 2000; Pelton et al., 2002; Rathjen et al., 1999) . SNAT1 immunoreactivity was detected in all cells of the E5.5 embryo, with a stronger signal seen in the embryonic portion of the embryo (Fig. 4A) . SNAT2 expression was primarily associated with the primitive ectoderm and overlying visceral endoderm population, with very little immunoreactivity detected in the extraembryonic portion of the embryo (Fig. 4A) .
In culture, EPL cells have been used as a model of the pluripotent cells within the E5.5 embryo (Rathjen et al., 1999) . EPL cells expressed SNAT1 and SNAT2, and the proteins were detected in aggregates adjacent to the nucleus and on the cell surface (Fig. 4B) , a pattern similar to that seen in primed ES cells. Analysis of Slc38a2 showed no significant difference in transcript levels between primed ES and EPL cells (Fig. 4C) . Human ES cells have been suggested to have parallels with mouse primitive ectoderm cells (Hughes et al., 2014) . Similar to EPL cells, SNAT2 protein accumulated in the perinuclear compartments of human ES cells. SNAT1 was localised proximal to or on the cell surface of human ES cells (Fig. S3A ). SLC38A1 and SLC38A2 transcripts were found to be present in human ES cells (Fig. S3B) . 
Discussion
Amino acid transporters in embryogenesis
Early embryogenesis in mammals has been extensively characterised morphologically, and the advent of molecular techniques has seen this description annotated to describe the emergence of cell populations and the progressive restriction of potency. It is still the case, however, that the signals that regulate embryo progression remain largely unknown.
An analysis of SNAT1 and SNAT2 expression in embryos was prompted by expression of these transporters in ES cells and the role SNAT2 plays in ES cell differentiation (Tan et al., 2011) . The transporters exhibited dynamic expression patterns in the early embryo, with levels of expression and subcellular location changing over time and with cell identity. The presence of sodium-coupled neutral amino acid transporters in preimplantation embryos, as shown here, had not been documented previously.
Differential transporter expression suggests that the interface of embryonic cells and the surrounding environment is dynamic. During preimplantation development, embryonic amino acid use is bi-phasic, with cleavage stage embryos relying more on those amino acids present at high levels in the oviduct and later stage blastocysts using all amino acids (Gardner, 2008; Lane and Gardner, 1997; Steeves and Gardner, 1999) . Oviduct fluid is characterised by high concentrations (typically greater than 1 mM) of L-alanine, L-aspartate, glycine, L-serine, L-glutamine, L-threonine and taurine; these concentrations are significantly higher than those found in uterine fluid (Harris et al., 2005; Miller and Schultz, 1987) . The benefit to the cleavage stage embryo conferred from those amino acids at high levels in the oviduct reflects the roles these amino acids fulfil as osmolytes, pH buffers, antioxidants and chelators. The concentrations of glycine and L-alanine in the oviductal fluid are sufficient to inhibit competitively SNAT1 and SNAT2 transporter activity and prevent the uptake of other substrates (Tan et al., 2011) . It can be predicted that before the embryo reaches the uterus, at around the 8-cell stage in the mouse, any SNAT1 and SNAT2 activity present will be dominated by the transport of glycine and L-alanine, preventing significant uptake of L-proline or other transporter substrates. It is, therefore, plausible that preimplantation embryo development, and potentially the progression of the pluripotent lineage, is regulated maternally by the competitive control of amino acid uptake through SNAT1 and SNAT2.
The period of development prior to implantation is recognised as particularly vulnerable to nutritional programming, and early embryos can show enduring responses to the environmental influences of the maternal environment, primarily through the impact of the environment on epigenetic and developmental events (reviewed in Fleming et al., 2015; Gardner and Harvey, 2015; Harvey et al., 2016) . When treated with L-proline ES cells acquire epigenetic changes associated with differentiation and EPL cell formation (Comes et al., 2013) , suggesting that in part the epigenetic programming of the embryo at this early stage of development can be regulated by transporter activity and the preferential uptake of amino acids from the environmental milieu. Control of L-proline uptake in early embryos may be essential to ensure the appropriate timing of epigenetic programming, particularly that associated with the formation and maturation of the primitive ectoderm (Comes et al., 2013; Hiratani et al., 2010) .
Much less is known of the role of SNAT1 and SNAT1 substrates in development. Different nutritional requirements may underlie the differential expression of SNAT1 on outer, but not inner, cells of the morula. The outer cells of the morula are the progenitors of the trophectoderm, a tissue that has been previously shown to have higher metabolic activity compared to the ICM (Hewitson and Leese, 1993; Houghton, 2006; Robinson and Benos, 1991) . Trophectoderm creates and responds to the metabolic cues of the uterine environment, supports embryonic development and modulates implantation (Gardner, 2015) . Preferential expression of SNAT1 in the emerging trophectoderm may reflect these different nutritional requirements.
The subcellular localisation of solute carrier family 38 members
Within mammalian cells that have been examined, SNAT2 is consistently localised to the plasma membrane and to a pool within the perinuclear space, localising with markers of the trans-Golgi network (Hatanaka et al., 2006; Hyde et al., 2001) . There are few reports of the subcellular localisation of SNAT1 in mammalian cells, although expression of the transporter has been demonstrated in numerous neural cell populations (Melone et al., 2004) . The protein has been detected throughout the cell body and the neural processes and appears as punctate staining at synapses in neurons (Armano et al., 2002) . In primed ES cells and EPL cells in culture SNAT1 and SNAT2 were detected at the cell membrane and in peri-nuclear stores. This is the first account of SNAT1 accumulation in the peri-nuclear space of a cell and suggests that, like SNAT2, the cell can store this transporter to enable a rapid response to nutritional stress. In the cleavage stage embryo, SNAT1 and SNAT2 are distributed evenly and diffusely in the cytoplasm and nucleus with no obvious localisation to the cell membrane or accumulation in intracellular stores. A diffuse staining pattern was also seen in naïve ES cells. The lack of localisation in these cells may indicate that blastomeres and early pluripotent cells do not have the appropriate structural environment to organise SNAT2 (Hatanaka et al., 2006) . Others have shown that the sodium-coupled neutral amino acid transporters are not active in oocytes and 2-cell and 8-cell stage embryos, suggesting that although the transporters are present they are not active (Van Winkle et al., 1990a) , potentially due to a lack of appropriate organisation.
The accumulation of SNAT2 in the nucleus of trophectoderm cells was seen in the blastocyst and confirmed in cultured cells. Nuclear SNAT2 in TS cells and in placental lines suggested this as a feature of the trophectoderm lineage. Protein sequence analysis of SNAT2 indicated the presence of a potential nuclear localisation signal (NLS), providing a possible means of localisation to the nucleus (data not shown). To date, there has been no other report of a transporter being present in the nucleus of a cell. Others have reported a nuclear-like localisation of SNAT2 in BeWo cells, although the pattern of staining was attributed to protein consolidation in the perinuclear space (Jones et al., 2006b ). The nuclear-like staining was lost when BeWo cells were starved of amino acids (Jones et al., 2006a) , suggesting that the proteins within the nucleus had the potential to be functional transporters that could be recruited to the cell surface for nutrient scavenging at times of cell need. Possibly, within the trophectoderm lineage, the site of SNAT2 storage has moved from aggregates in the perinuclear space to a store located within the nucleus.
Amino acid transporters in the pluripotent lineage
The transition of primed ES cells to EPL cells mimics the formation of the primitive ectoderm from the ICM of the E4.5 embryo (Rathjen et al., 1999) and SNAT2 has been shown to be involved in this transition in culture (Tan et al., 2011) . In the embryo, SNAT2 expression was low in the ICM of the expanding E3.5 blastocyst but was increased in subsequent pluripotent cell populations. The increase of SNAT2 in the pluripotent cells of the embryo marks the transition between early and late ICM and precedes the formation of primitive ectoderm (Boroviak et al., 2014) . Gene expression analysis of Slc38a2 and immunofluorescence data from naïve and primed ES cells suggests that transporter regulation occurs, in part, at the level of transcription. Slc38a2 expression has shown to be regulated by nutrients through the general control nonderepressible 2 (GCN2) and insulin-like growth factor-1 (IGF-1) pathways (Gaccioli et al., 2006; Jones et al., 2009 Jones et al., , 2013 Palii et al., 2006) . In addition, pathways integral to the regulation of pluripotency have been shown to regulate Slc38a2 expression, including IL-6, Stat3 and ERK1/2 (Carr et al., 2010; Franchi-Gazzola et al., 1999; Jones et al., 2009; Lopez-Fontanals et al., 2003) . Erk1/2 has been shown to be required for Slc38a2 activity in amino acid-starved human fibroblasts (Franchi-Gazzola et al., 1999) and Slc38a2 expression in amino acidstarved Chinese hamster ovary (CHO) cells (Lopez-Fontanals et al., 2003) . In differentiating T cells, Erk/MAPK signalling is required for Slc38a1 and Slc38a2 transcription and SNAT2 protein expression (Carr et al., 2010) . In culture, pluripotent cells undergo the transition between an Erk-independent ES cell state (naïve ES cells) Ying et al., 2008) to an ERK1/2-dependent state (primed ES cells and EPL cells, JR unpublished), and naïve ES cells form from primed ES cells when Erk1/2 signalling is inhibited (Ying et al., 2008) . SNAT2 levels were low in naïve ES cells when compared to the same cells cultured as primed cells, and the inhibition of Erk1/2 in primed ES cells resulted in decreased Slc38a2 expression. These data raise the possibility that Slc38a2 expression is Erk responsive in pluripotent cells.
In this study we have shown an increase in SNAT2 expression in the pluripotent cells of the embryo prior to primitive ectoderm formation. This expression pattern is consistent with the expression in primed, but not naïve, cells, and with a role for the transporter in later developmental decisions within the pluripotent lineage akin to the role we have documented in ES cell differentiation in culture. We propose that the differential expression of SNAT2 in the pluripotent epiblast is consistent with an L-proline-mediated mechanism contributing to the regulation of embryonic development.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.mod.2016.06.003.
